Your browser doesn't support javascript.
loading
Pharmacokinetics and safety of subcutaneous pasireotide and intramuscular pasireotide long-acting release in Chinese male healthy volunteers: a phase I, single-center, open-label, randomized study.
Chen, Xia; Shen, Guoxiang; Jiang, Ji; Liu, Hongzhong; Hu, Ke; Darstein, Christelle; Lasher, Janet; Hu, Pei.
Afiliação
  • Chen X; Clinical Pharmacology Research Centre, Peking Union Medical College Hospital, Beijing, China.
  • Shen G; Novartis Pharmaceutical Corporation, Oncology Business Unit, East Hanover, New Jersey.
  • Jiang J; Clinical Pharmacology Research Centre, Peking Union Medical College Hospital, Beijing, China.
  • Liu H; Clinical Pharmacology Research Centre, Peking Union Medical College Hospital, Beijing, China.
  • Hu K; Novartis Pharmaceutical Corporation, Oncology Business Unit, East Hanover, New Jersey.
  • Darstein C; Novartis Pharma AG, Basel, Switzerland.
  • Lasher J; Novartis Pharmaceutical Corporation, Oncology Business Unit, East Hanover, New Jersey.
  • Hu P; Clinical Pharmacology Research Centre, Peking Union Medical College Hospital, Beijing, China. Electronic address: pei.hu.pumc@gmail.com.
Clin Ther ; 36(8): 1196-210, 2014 Aug 01.
Article em En | MEDLINE | ID: mdl-25012727
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Somatostatina Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Somatostatina Idioma: En Ano de publicação: 2014 Tipo de documento: Article